Physician profile
Anuj Jain
NPI 1295821585
$1,318.63
in general payments reported to CMS, 2019-2025
22 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $409 · 2020: $136 · 2021: $352 · 2022: $50.14 · 2023: $99.38 · 2024: $140 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $197.58 | 2019-2021 | |
| Pfizer INC. | $151.83 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.74 | 2019-2024 | Lifevest |
| Cvrx, INC. | $122.56 | 2021 | |
| Merck Sharp & Dohme LLC | $74.97 | 2024-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $72.97 | 2019-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $67.47 | 2019-2025 | Jardiance |
| Scpharmaceuticals INC. | $43.66 | 2023-2024 | |
| Heartflow, INC. | $41.58 | 2024 | |
| Boston Scientific Corporation | $33.33 | 2019-2021 | |
| Amarin Pharma, INC. | $29.19 | 2019 | |
| Amgen INC. | $24.31 | 2023 | Repatha |
| Medtronic, INC. | $23.80 | 2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $18.09 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $15.85 | 2019 | |
| Gilead Sciences, INC. | $15.51 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.59 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $13.20 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.00 | 2020 | |
| Chiesi USA, INC. | $12.40 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.